Dominique Potin
AbbVie (United States) · 29 works · 505 citations · h-index 14
Top works
- New chiral auxiliaries: their use in the asymmetric hydrogenation of .beta.-acetamidocrotonates
- Asymmetric Protonation of Enolates
- Improved Asymmetric Synthesis of 8-Arylmenthols
- Asymmetrische Protonierung von Enolaten
- New chiral auxiliaries derived from β -pinene: Their use in the asymmetric reduction of β-keto-esters
- Novel 3-(4-piperidinylthio)-1H-indoles as potent nonopioid orally active central analgesics
- Small Molecule Antagonist of Leukocyte Function Associated Antigen-1 (LFA-1): Structure−Activity Relationships Leading to the Identification of 6-((5S,9R)-9-(4-Cyanophenyl)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]nonan-7-yl)nicotinic Acid (BMS-688521)
- De novo design, synthesis, and in vitro activity of LFA-1 antagonists based on a bicyclic[5.5]hydantoin scaffold
- Discovery and Development of 5-[(5S,9R)-9- (4-Cyanophenyl)-3-(3,5-dichlorophenyl)-1- methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]non- 7-yl-methyl]-3-thiophenecarboxylic Acid (BMS-587101)A Small Molecule Antagonist of Leukocyte Function Associated Antigen-1
- Discovery of Selective and Orally Bioavailable Protein Kinase Cθ (PKCθ) Inhibitors from a Fragment Hit
- Enzymatic resolution of hindered secondary alcohols: Efficient access to a new simplified chiral auxiliary
- Optimisation of 2-cyano-pyrimidine inhibitors of cathepsin K: Improving selectivity over hERG
- An LFA-1 (αLβ2) Small-Molecule Antagonist Reduces Inflammation and Joint Destruction in Murine Models of Arthritis
- Design and optimization of a series of novel 2-cyano-pyrimidines as cathepsin K inhibitors
- Design of LFA-1 antagonists based on a 2,3-dihydro-1H-pyrrolizin-5(7aH)-one scaffold
- 2-Phenyl-9H-purine-6-carbonitrile derivatives as selective cathepsin S inhibitors
- Discovery of novel quinoline sulphonamide derivatives as potent, selective and orally active RORγ inverse agonists
- Inhibition of Interleukin-23–Mediated Inflammation with a Novel Small Molecule Inverse Agonist of RORγt
- (±)-3-Methyl-1,1-diphenyl-2-butyl 3-Acetamidocrotonate and its Hydrogenation Product
- ChemInform Abstract: New Chiral Auxiliaries: Their Use in the Asymmetric Hydrogenation of β‐Acetamidocrotonates.